Use of latanoprost to reduce acute intraocular pressure rise following neodymium: Yag laser iridotomy

Acta Ophthalmol Scand. 2002 Jun;80(3):282-6. doi: 10.1034/j.1600-0420.2002.800310.x.

Abstract

Purpose: To evaluate the efficacy of latanoprost in reducing acute intraocular pressure (IOP) elevation after neodymium:Yag laser iridotomy (LI).

Methods: Primary angle-closure glaucoma (PACG) eyes were randomized to receive premedication with latanoprost and pilocarpine or with pilocarpine only before LI. Postoperative IOP changes were compared with Wilcoxon signed-ranks test using the fellow eyes of 47 patients who had one eye in each group.

Results: Postoperative pressure spikes were significantly lower (p = 0.010) in the latanoprost group (4.1 +/- 5.0 mmHg) than in the control group (6.7 +/- 7.0 mmHg). Mean elevation of IOP was less in the latanoprost group than in the control group at 1 hour (2.5 +/- 4.8 versus 4.1 +/- 4.7 mmHg, p = 0.013) and 2 hours (0.8 +/- 5.6 versus 4.4 +/- 8.1 mmHg, p = 0.003) postoperatively. Eleven eyes in the latanoprost group (23.4%) and 20 eyes in the control group (42.6%) developed a rise in IOP > or = 6 mmHg (p = 0.048).

Conclusion: Latanoprost may reduce the pressure rise following LI in PACG eyes, but its application is limited by a late onset of effect.

Publication types

  • Clinical Trial
  • Evaluation Study
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents / therapeutic use*
  • Female
  • Glaucoma, Angle-Closure / surgery*
  • Humans
  • Intraocular Pressure / drug effects*
  • Iris / surgery*
  • Laser Therapy / adverse effects*
  • Latanoprost
  • Male
  • Middle Aged
  • Ocular Hypertension / drug therapy*
  • Ocular Hypertension / etiology
  • Pilocarpine / therapeutic use
  • Premedication
  • Prostaglandins F, Synthetic / therapeutic use*
  • Safety
  • Tonometry, Ocular
  • Treatment Outcome
  • Visual Acuity

Substances

  • Antihypertensive Agents
  • Prostaglandins F, Synthetic
  • Pilocarpine
  • Latanoprost